Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Kim, Dong-Wook  [Clear All Filters]
2024
Yoon H, Kang JH, Cho SWoo, Park CGwon, Kim D-W, Park T-E. Brain-decellularized ECM-based 3d Myeloid Sarcoma Platform: Mimicking Adaptive Phenotypic Alterations in The Brain. Adv Healthc Mater. 2024:e2304371.
Park S, Park CWook, Eom JHyeon, Jo M-Y, Hur H-J, Choi SKyoung, Lee JSouk, Nam STaek, Jo K-S, Oh YWoo, et al. Preclinical and dose-ranging assessment of hESC-derived dopaminergic progenitors for a clinical trial on Parkinson's disease. Cell Stem Cell. 2024;31(2):278-279.
2023
Yeon G-B, Jeon B-M, Yoo SHyun, Kim D, Oh SSoo, Park S, Shin W-H, Kim HWook, Na D, Kim D-W, et al. Differentiation of astrocytes with characteristics of ventral midbrain from human embryonic stem cells. Stem Cell Rev Rep. 2023.
Park S, Park CWook, Eom JHyeon, Jo M-Y, Hur H-J, Choi SKyoung, Lee JSouk, Nam STaek, Jo K-S, Oh YWoo, et al. Preclinical and dose-ranging assessment of hESC-derived dopaminergic progenitors for a clinical trial on Parkinson's disease. Cell Stem Cell. 2023.
2021
Cho B-S, Yahng S-A, Min G-J, Park S, Park S-S, Shin S-H, Jeon Y-W, Yoon J-H, Lee S-E, Eom K-S, et al. Comparable outcomes after alternative and matched sibling donor hematopoietic stem cell transplantation and the role of molecular measurable residual disease for acute myeloid leukemia in elderly patients. Transplant Cell Ther. 2021.
Jung J, Hwang S, Seol H, Kim A-H, Lee HMyoung, Sung JJea, Jeong SMin, Choi YMin, Jun JKwan, Kim D-W, et al. Generation of Brachyury-mCherry knock-in reporter human pluripotent stem cell line (SNUe003-A-2) using CRISPR/CAS9 nuclease. Stem Cell Res. 2021;53:102321.
2020
Park S, Min GJune, Park SSoo, Yahng S-A, Jeon Y-W, Shin S-H, Yoon J-H, Lee S-E, Cho BSik, Eom K-S, et al. Comparison of myeloablative (CyTBI, BuCy) versus reduced-intensity (FluBu2TBI400) peripheral blood stem cell transplantation in acute myeloid leukemia patients with pre-transplant low WT1 expression. Biol Blood Marrow Transplant. 2020.
Kim D-H, Park C-Y, Cho S-R, Kim D-W. Generation of a human induced pluripotent stem cell line, YCMi002-A, from a Factor VII deficiency patient carrying F7 mutations. Stem Cell Res. 2020;49:102026.
Shin S-H, Park S-S, Park S, Jeon Y-W, Yoon J-H, Yahng S-A, Cho B-S, Kim Y-J, Lee S, Kim H-J, et al. Nonmyeloablative matched sibling stem cell transplantation with the optional reinforced stem cell infusion for patients with hemoglobinopathies. Eur J Haematol. 2020.
2019
Lee S-E, Lim J-Y, Bin Ryu D-, Kim TWoo, Park SSoo, Jeon Y-W, Yoon J-H, Cho B-S, Eom K-S, Kim Y-J, et al. Alteration of the intestinal microbiota by broad-spectrum antibiotic use correlates with the occurrence of intestinal graft-versus-host disease. Biol Blood Marrow Transplant. 2019.
Lee HLim, Jang JWon, Han JWon, Lee SWon, Bae SHyun, Choi JYoung, Han NIk, Yoon SKew, Kim H-J, Lee S, et al. Early Hepatitis B Surface Antigen Seroclearance Following Antiviral Treatment in Patients with Reactivation of Resolved Hepatitis B. Dig Dis Sci. 2019.
Park S, Yoo J-E, Lee DR, Jang J, Cho MSoo, Kim D-S, Kim D-W. Establishment of PITX3-mCherry knock-in reporter human embryonic stem cell line (WAe009-A-23). Stem Cell Res. 2019;39:101499.
Cho B-S, Min G-J, Park S-S, Shin S-H, Yahng S-A, Jeon Y-W, Yoon J-H, Lee S-E, Eom K-S, Kim Y-J, et al. WT1 measurable residual disease assay in AML who underwent allogeneic hematopoietic stem cell transplantation; optimal time points, threshold, and candidates. Biol Blood Marrow Transplant. 2019.
2018
Lee J, Choi S-H, Kim Y-B, Jun I, Sung JJea, Lee DR, Kim YIn, Cho MSoo, Byeon SHo, Kim D-S, et al. Defined Conditions for Differentiation of Functional Retinal Ganglion Cells From Human Pluripotent Stem Cells. Invest Ophthalmol Vis Sci. 2018;59(8):3531-3542.
2016
Park C-Y, Sung JJea, Choi S-H, Lee DR, Park I-H, Kim D-W. Modeling and correction of structural variations in patient-derived iPSCs using CRISPR/Cas9. Nat Protoc. 2016;11(11):2154-2169.
2015
Naka K, Ishihara K, Jomen Y, Jin CHua, Kim D-H, Gu Y-K, Jeong E-S, Li S, Krause DS, Kim D-W, et al. The novel oral TGF-β signaling inhibitor EW-7197 eradicates chronic myelogenous leukemia-initiating cells. Cancer Sci. 2015.
Yoon J-H, Kim H-J, Jeon Y-W, Lee S-E, Cho B-S, Eom K-S, Kim Y-J, Lee S, Min C-K, Cho S-G, et al. Outcome of allogeneic hematopoietic stem cell transplantation for cytogenetically normal AML and identification of high-risk subgroup using WT1 expression in association with NPM1 and FLT3-ITD mutations. Genes Chromosomes Cancer. 2015.
Seo HIn, Cho A-N, Jang J, Kim D-W, Cho S-W, Chung BGeun. Thermo-responsive polymeric nanoparticles for enhancing neuronal differentiation of human induced pluripotent stem cells. Nanomedicine. 2015.
2014
Kim H-S, Choi S-M, Yang W, Kim D-S, Lee DR, Cho S-R, Kim D-W. PSA-NCAM(+) Neural Precursor Cells from Human Embryonic Stem Cells Promote Neural Tissue Integrity and Behavioral Performance in A Rat Stroke Model. Stem Cell Rev. 2014.
Park C-Y, Kim J, Kweon J, Son JSang, Lee JSouk, Yoo J-E, Cho S-R, Kim J-H, Kim J-S, Kim D-W. Targeted inversion and reversion of the blood coagulation factor 8 gene in human iPS cells using TALENs. Proc Natl Acad Sci U S A. 2014.
2013
Eom K-S, Shin S-H, Yoon J-H, Yahng S-A, Lee S-E, Cho B-S, Kim Y-J, Kim H-J, Min C-K, Kim D-W, et al. Comparable long-term outcomes after reduced-intensity conditioning versus myeloablative conditioning allogeneic stem cell transplantation for adult high-risk acute lymphoblastic leukemia in complete remission. Am J Hematol. 2013.
Min C-K, Lee S-E, Yahng S-A, Cho B-S, Eom K-S, Kim Y-J, Kim H-J, Lee S, Cho S-G, Kim D-W, et al. The impact of novel therapeutic agents before and after frontline autologous stem cell transplantation in patients with multiple myeloma. Blood Res. 2013;48(3):198-205.
Yoon J-H, Kim H-J, Shin S-H, Yahng S-A, Cho B-S, Eom K-S, Kim Y-J, Lee S, Min C-K, Cho S-G, et al. Normal karyotype mosaicism in adult AML patients with adverse-risk and undefined karyotype: preliminary report of treatment outcomes after hematopoietic stem cell transplantation. Int J Hematol. 2013.